ParcelBio jobs and careers

San Francisco, CA, USA

About ParcelBio

ParcelBio is engineering a new class of mRNA medicines designed to deliver unprecedented potency and durability. Its proprietary APEXm™ platform uses novel RNA domains to enhance protein expression and extend activity, enabling therapies that reach the thresholds required for meaningful, and potentially curative, clinical outcomes. The company is advancing programs in autoimmune disease, oncology, and encoded protein therapeutics.

Founded in 2024 by Christopher Carlson and David Weinberg.

Biopharma Biotechnology